HSV-1 and HSV-2 are closely related viruses that both cause herpes, but they differ in where they typically show up, how often they come back, and how frequently they spread without symptoms. About 64% of the global population under 50 carries HSV-1, while HSV-2 is far less common. Understanding which type you have matters because it directly affects what you can expect going forward.
Where Each Type Prefers to Live
HSV-1 is traditionally the “oral” herpes virus. It spreads mainly through mouth-to-mouth contact and causes cold sores on or around the lips. HSV-2 spreads primarily through sexual contact and causes sores in the genital area. But these labels are misleading if taken too literally.
HSV-1 increasingly causes genital herpes too, transmitted through oral sex. The World Health Organization estimates that of the 3.8 billion people worldwide carrying HSV-1, roughly 376 million have genital infections from the virus. So while each type has a preferred site, both can infect either location. The type matters less than you might think for diagnosing where your infection is, but it matters a lot for predicting how it will behave over time.
Outbreaks Look the Same, but Recurrence Rates Differ Sharply
During a first outbreak, HSV-1 and HSV-2 are clinically indistinguishable. Both start with a prodrome of tingling, burning, or pain at the site. Small fluid-filled blisters appear, then rupture into shallow ulcers that crust over and heal. In moist areas like the mouth or genitals, the sores stay open longer. In dry skin areas, they scab. Genital sores from either type typically last 4 to 15 days before the skin fully heals, while oral outbreaks run about 5 to 7 days with symptoms fading over two weeks.
The real separation between the two types shows up in what happens after that first episode. Genital HSV-2 recurs frequently, often multiple times in the first year and continuing at a significant rate for years. Genital HSV-1, by contrast, tends to recur about once during the first year and then drops off quickly. Research from the University of Washington confirms that genital HSV-1 is “substantially less severe” than genital HSV-2 in terms of both recurrences and viral shedding.
Oral HSV-1, the classic cold sore, recurs at a moderate rate for most people, with triggers like stress, sun exposure, illness, or fatigue bringing on occasional flare-ups. Oral HSV-2 is rare and recurs even less often than oral HSV-1.
Viral Shedding Between Outbreaks
Both types shed virus even when no sores are visible, which is one of the main reasons herpes spreads so easily. Most people who transmit the virus do so during these asymptomatic periods. HSV-2 sheds far more frequently than HSV-1 at the genital site. This higher shedding rate is the primary reason genital HSV-2 is more likely to be passed to a partner than genital HSV-1.
For genital HSV-1, shedding drops rapidly during the first year of infection and stays low. Researchers have not been able to pinpoint a clear biological mechanism for this difference. Analysis of the viruses and the immune response to them hasn’t explained why HSV-1 goes quieter at the genital site while HSV-2 remains persistently active there.
How Common Each Type Is
HSV-1 is one of the most widespread infections on the planet. As of the latest WHO estimates from 2020, 3.8 billion people under 50, or 64% of the global population, carry it. Most people pick it up during childhood through casual contact like a kiss from a family member.
HSV-2 is much less prevalent, concentrated in sexually active adults. Rates vary widely by region and population, but it is far less universal than HSV-1. One important trend: because fewer young people are acquiring HSV-1 in childhood in higher-income countries, more of them reach sexual maturity without any herpes antibodies. This leaves them vulnerable to picking up HSV-1 as a genital infection through oral sex, which is why genital HSV-1 has been rising in younger populations.
Testing and Telling Them Apart
If you have an active sore, a swab test can identify the virus directly and tell you the type. This is the most reliable method. If there are no sores present, a type-specific blood test (IgG antibody test) can determine whether you carry HSV-1, HSV-2, or both, though these tests have limitations worth knowing about.
Blood tests for HSV-2 perform well, with sensitivity above 97% and specificity above 98% on the best-performing platforms. That means they catch nearly all true infections while rarely producing false positives. HSV-1 blood tests are less reliable. Sensitivity drops to around 80 to 84% on the most commonly used tests, meaning they miss roughly one in five infections. One platform achieves 92% sensitivity but at the cost of lower specificity (88.7%), which means more false positives.
Blood tests also can’t tell you where your infection is. A positive HSV-1 IgG result could mean oral herpes, genital herpes, or both. Only a swab during an active outbreak can confirm the site. It takes time after initial exposure for antibodies to build up enough to be detectable, so testing too early after a possible exposure can produce a false negative.
Neurological Complications
Both types can, in rare cases, cause serious neurological problems. Herpes encephalitis, an infection of the brain, is most commonly caused by HSV-1. It can lead to seizures, memory problems, personality changes, and difficulty with thinking, movement, hearing, or vision. Without treatment, it can be fatal. Even with treatment, severe cases can result in lasting brain damage.
HSV-2 is more commonly associated with herpes meningitis, an infection of the membranes surrounding the brain and spinal cord. This is generally less dangerous than encephalitis but can recur. Newborns face a particular risk from HSV-2 if they are exposed during delivery, which can cause neonatal herpes encephalitis.
Treatment Is the Same for Both
Antiviral medications work identically against both types. The same drugs are used whether you have HSV-1 or HSV-2, oral or genital. Treatment can be taken during outbreaks to shorten their duration and reduce severity, or taken daily as suppressive therapy to reduce recurrence frequency and lower the risk of transmission to partners.
Because genital HSV-2 recurs more often and sheds more frequently, daily suppressive therapy tends to be more commonly recommended for people with that diagnosis. Someone with genital HSV-1 who has rare recurrences may find that episodic treatment, taking medication only when an outbreak starts, is sufficient. Your type and location of infection are the two biggest factors in deciding which approach makes sense.
Why Knowing Your Type Matters
The practical difference comes down to prognosis. If you test positive for genital herpes and it turns out to be HSV-1, you can generally expect infrequent outbreaks that taper off quickly, lower rates of asymptomatic shedding, and a relatively low risk of transmitting the virus to a partner from the genital site. If it’s HSV-2, recurrences and shedding will likely be more persistent, and daily suppressive therapy may be worth considering for both symptom control and transmission reduction.
Neither type is more “serious” in the sense of being a different disease. They cause the same kinds of sores, respond to the same treatments, and both establish lifelong infection. But the pattern of recurrence and shedding is different enough that knowing your type gives you real, useful information about what your experience is likely to look like going forward.